title: Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact.
abstract: The relationship between Hepatitis C Virus (HCV) infection and immunosuppression is complex and multifaceted. Although HCV-related hepatocytolysis is classically interpreted as secondary to the attack by cytotoxic T lymphocytes against infected cells, the liver disease is usually exacerbated and more rapidly evolutive in immunosuppressed patients. This generally occurs during the immunosuppression state, and not at the reconstitution of the host response after immunosuppressive therapy discontinuation. The field of immunosuppression and HCV infection is complicated both by the different outcome observed in different situations and/or by contrasting data obtained in the same conditions, with several still unanswered questions, such as the opportunity to modify treatment schedules in the setting of post-transplant follow-up. The complexity of this field is further complicated by the intrinsic tendency of HCV infection in itself to lead to disorders of the immune system. This review will briefly outline the current knowledge about the pathogenesis of both hepatic and extrahepatic HCV-related disorders and the principal available data concerning HCV infection in a condition of impairment of the immune system. Attention will be especially focused on some conditions - liver or kidney transplantation, the use of biologic drugs and cancer chemotherapy - for which more abundant and interesting data exist.
authors.affiliation: Center for Systemic Manifestations of Hepatitis Viruses (MASVE), Department of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. a.zignego@dmi.unifi.it
authors.forename: Anna Linda
authors.initials: AL
authors.lastname: Zignego
authors.forename: Carlo
authors.initials: C
authors.lastname: Giannini
authors.forename: Laura
authors.initials: L
authors.lastname: Gragnani
authors.forename: Alessia
authors.initials: A
authors.lastname: Piluso
authors.forename: Elisa
authors.initials: E
authors.lastname: Fognani
mesh_terms: D000818:Animals; D002869:Chromosome Aberrations; D006526:Hepatitis C / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host